Evidence map›Paper›PMID 29717118›Full record

ArticleNature communications2018

Distinct mutational signatures characterize concurrent loss of polymerase proofreading and mismatch repair.

N J Haradhvala, J Kim, Y E Maruvka, P Polak, D Rosebrock, D Livitz, J M Hess, I Leshchiner, A Kamburov, K W Mouw and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 124 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
124citing papers in PubMed, 1 pooled it
8.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

124 citing papers in PubMed, 1 synthesis or guideline pooled it, 197 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Case Report: Expansion of theFrontiers in oncology · 2025
    Article
  20. Article

64 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

N J HaradhvalaDepartment of Pathology and Cancer Center, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA.
J KimBroad Institute of Harvard and MIT, 415 Main Street, Cambridge, MA, 02142, USA.
Y E MaruvkaBroad Institute of Harvard and MIT, 415 Main Street, Cambridge, MA, 02142, USA.
P PolakDepartment of Pathology and Cancer Center, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA.ORCID http://orcid.org/0000-0002-2153-4488
D RosebrockBroad Institute of Harvard and MIT, 415 Main Street, Cambridge, MA, 02142, USA.
D LivitzBroad Institute of Harvard and MIT, 415 Main Street, Cambridge, MA, 02142, USA.ORCID http://orcid.org/0000-0003-2528-1446
J M HessBroad Institute of Harvard and MIT, 415 Main Street, Cambridge, MA, 02142, USA.
I LeshchinerBroad Institute of Harvard and MIT, 415 Main Street, Cambridge, MA, 02142, USA.ORCID http://orcid.org/0000-0001-8942-9265
A KamburovDepartment of Pathology and Cancer Center, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA.
K W MouwHarvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA.
M S LawrenceDepartment of Pathology and Cancer Center, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA.
G GetzDepartment of Pathology and Cancer Center, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA. gadgetz@broadinstitute.org.ORCID http://orcid.org/0000-0002-0936-0753
Broad Institute · USHarvard University · US

Funding

Harvard Clinical and Translational Science CenterUL1TR001102 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2013 to 2017
$106.2M
The Cancer Genome Atlas Data Analysis CenterU24CA143845 · NCI · BROAD INSTITUTE, INC. · PI CHIN, LYNDA, GETZ, GAD A · 2009 to 2016
$16.0M
Investigating the effect of ERCC2 mutations on DNA repair capacity and chemo-radiotherapy response in muscle-invasive bladder cancerK08CA219504 · NCI · DANA-FARBER CANCER INST · PI MOUW, KENT W · 2017 to 2021
$885k
NCATS NIH HHS UL1 TR001102NCI NIH HHS K08 CA219504NCI NIH HHS U24 CA143845
6 · The paper itself

Abstract

Fidelity of DNA replication is maintained using polymerase proofreading and the mismatch repair pathway. Tumors with loss of function of either mechanism have elevated mutation rates with characteristic mutational signatures. Here we report that tumors with concurrent loss of both polymerase proofreading and mismatch repair function have mutational patterns that are not a simple sum of the signatures of the individual alterations, but correspond to distinct, previously unexplained signatures: COSMIC database signatures 14 and 20. We then demonstrate that in all five cases in which the chronological order of events could be determined, polymerase epsilon proofreading alterations precede the defect in mismatch repair. Overall, we illustrate that multiple distinct mutational signatures can result from different combinations of a smaller number of mutational processes (of either damage or repair), which can influence the interpretation and discovery of mutational signatures.

Indexed as

DNA Mismatch RepairMutationCohort StudiesDatabases, GeneticDNA Polymerase IIDNA Polymerase IIIDNA ReplicationEndometrial NeoplasmsFemaleGenome, HumanHumansDNA Polymerase IIDNA Polymerase III

Identifiers

PMID29717118
PMCPMC5931517
OpenAlexW2799563655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.